Dissecting residual disease in spheroids reveals pan-cancer persistence signatures and a therapeutic window for oncolytic viruses.
Saved in:
| Title: | Dissecting residual disease in spheroids reveals pan-cancer persistence signatures and a therapeutic window for oncolytic viruses. |
|---|---|
| Authors: | Fauveau C; Transgene, 67400 Illkirch-Graffenstaden, France.; Institute of Genetics and Molecular and Cellular Biology (IGBMC), 67404 Illkirch-Graffenstaden, France.; CNRS UMR 7104, 67404 Illkirch-Graffenstaden, France.; Inserm U1258, 67404 Illkirch-Graffenstaden, France.; University of Strasbourg, 67404 Illkirch-Graffenstaden, France., Lawendy E; Transgene, 67400 Illkirch-Graffenstaden, France., Deforges J; Transgene, 67400 Illkirch-Graffenstaden, France., Cochin S; Transgene, 67400 Illkirch-Graffenstaden, France., Moreau B; Transgene, 67400 Illkirch-Graffenstaden, France., Balloul JM; Transgene, 67400 Illkirch-Graffenstaden, France., Erbs P; Transgene, 67400 Illkirch-Graffenstaden, France., Jain S; Transgene, 67400 Illkirch-Graffenstaden, France., Laverny G; Institute of Genetics and Molecular and Cellular Biology (IGBMC), 67404 Illkirch-Graffenstaden, France.; CNRS UMR 7104, 67404 Illkirch-Graffenstaden, France.; Inserm U1258, 67404 Illkirch-Graffenstaden, France.; University of Strasbourg, 67404 Illkirch-Graffenstaden, France. |
| Corporate Authors: | PERSIST-SEQ Consortium |
| Source: | Molecular therapy. Oncology [Mol Ther Oncol] 2026 Jun 19; Vol. 34 (3), pp. 201279. Date of Electronic Publication: 2026 Jun 19 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9918752083706676 Publication Model: eCollection Cited Medium: Print ISSN: 2950-3299 (Print) Linking ISSN: 29503299 NLM ISO Abbreviation: Mol Ther Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
